Skip to main content
SpringerLink
Log in

Priming of NADPH oxidase by tumor necrosis factor alpha in patients with inflammatory and autoimmune rheumatic diseases

  • Original Articles
  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

Oxidative damage caused by oxygen free radicals from activated phagocytes contributes to the pathology of arthritis. The present study evaluates the activity of NADPH oxidase of neutrophils and monocytes from patients suffering from various inflammatory and autoimmune rheumatic diseases. Production rates of reactive oxygen species [ROS] of neutrophils and monocytes from rheumatic patients are compared to those of healthy controls and non-rheumatic disease controls and correlated with the plasma levels of tumor necrosis factor alpha, C-reactive protein and the sedimentation rates of erythrocytes. There was a two- to eightfold increase in phagocytic superoxide production in rheumatic patients, when compared to healthy subjects or patients with non-rheumatic internal diseases [p<0.005]. The enhanced NADPH oxidase-dependent Superoxide generation correlated well with elevated levels of tumor necrosis factor alpha [TNF-α] in plasma [p=0.005], suggesting a causal relation. There was no correlation with the plasma levels of C-reactive protein and a weak though significant correlation with the sedimentation rates of erythrocytes [p=0.043]. Removal of circulating TNF-α by dialysis of patients' blood and inhibition of NADPH oxidase by prednisolone treatment normalized elevated ROS production to the levels of healthy controls and correlated with the clinical improvements. Our data support the hypothesis of a central role for TNF-α during the development of arthritis. The chemiluminescence assay described here may be useful as a convenient screen and as a potential follow up procedure for individual patients with rheumatic diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Rossi, F. 1986. The O −2 forming NADPH oxidase of the phagocytes: nature, mechanisms of activation and function.Biochim. Biophy. Acta 853:65–89.

    Google Scholar 

  2. Miesel, R., andM. Zuber. 1993. Reactive nitrogen intermediates, antinuclear antibodies and copper-thionein in serum of patients with rheumatic diseases.Rheumatol. Int. 13:95–102.

    Google Scholar 

  3. Babior, B. M., J. T. Curnutte, andB. J. McMurrich. 1976. The paniculate superoxide-forming system from human neutrophils. Properties of the system and further evidence supporting its involvement in the respiratory burst.J. Clin. Invest. 58:989–996.

    Google Scholar 

  4. De Sole, P. 1992. Recent developments in clinical applications of cellular luminescence.In: P. E. Stanely, and L. J. Krick, editors. Bioluminescence and Chemiluminescence. Wiley, New York, pp. 245–252.

    Google Scholar 

  5. Gupta, J. W., M. Kubin, L. Hartman, M. Casatella, andG. Trinchieri. 1992. Induction of expression of genes encoding components of the respiratory burst oxidase during differentiation of human myeloid cell lines induced by tumour necrosis factor and gamma-interferon.Cancer Res. 52:2530–2537.

    Google Scholar 

  6. Utsumi, T. J., K. Klostergaard, K. Akimaru, E. F. Edashige, L. Sato, andK. Utsumi. 1992. Modulation of TNF-alpha-priming and stimulation-dependent superoxide generation in human neutrophils by protein kinase inhibitors.Arch. Biochem. Biophys. 294:271–278.

    Google Scholar 

  7. Beutler, B., andA. Cerami. 1989. The biology of cachectin/TNF: a primary mediator of the host response.Annu. Rev. Immunol. 7:625–655.

    Google Scholar 

  8. Fiers, W. 1989. Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level.FEBS Lett. 285:199–212.

    Google Scholar 

  9. Beutler, B. 1992. Tumor necrosis factors:In: The molecules and their emerging role in medicine. Raven Press, New York.

    Google Scholar 

  10. Tetta, C., G. Camussi, V. Modena, C. Di Vittoria, andC. Baglioni. 1990. Tumor necrosis factor in serum and synovial fluid of patients with active and severe rheumatoid arthritis.Ann. Rheum. Dis. 49:665–667.

    Google Scholar 

  11. Aloe, L., L. Probert, G. Kollias, L. Bracci-Laudieri, M. G. Spillantini, andR. Levi-Montalcini. 1993. The synovium of transgenic arthritic mice expressing human tumor necrosis factor contains a high level of nerve growth factor.Growth Factors 9:149–155.

    Google Scholar 

  12. Gyllenhammar, H. 1987. Lucigenin chemiluminescence in the assessment of neutrophil superoxide production.J. Immunol. Meth. 97:209–213.

    Google Scholar 

  13. Blair, A. L., L. A. Cree, J. S. Beck, andJ. G. M. Hastings. 1988. Measurement of phagocyte chemiluminescence in a microtitre plate formate.J. Immunol. Meth. 112:163–168.

    Google Scholar 

  14. Newburger, P. E., H. J. Cohen, S. B. Rothschild, J. C. Hobbins, S. E. Malawiste, andM. J. Mahoney. 1979. Prenatal diagnosis of chronic granulomatous disease.N. Engl. J. Med. 300:178–181.

    Google Scholar 

  15. Fisher, A., P. H. Trung, B. Descamps-Latscha, I. Lisoska-Grospierre, L. Gerota, N. P. Perez, C. Scheinmetzler, A. Durandy, J. L. Virelizier, andC. Griselli. 1983. Bone marrow transplantation for inborn error of phagocytic cells associated with defective adherence, chemotaxis, and oxidative response during opsonised particle phagocytosis.Lancet 2:473–476.

    Google Scholar 

  16. Root, R. K., A. S. Rosenthal, andD. J. Balestra. 1972. Abnormal bactericidal metabolic and lysosomal functions of Chediak-Higashi syndrome leukocytes.J. Clin. Invest. 51:649–658.

    Google Scholar 

  17. Riordan, J. R., J. M. Rommers, andB. S. Kerem. 1989. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.Science 245:1067–1072.

    Google Scholar 

  18. De Simone, C., P. De Sole, G. Di Marco, A. Venier, D. Cerimele, andF. Serri. 1989. Reactive oxygen species production in circulating polymorphonuclear leukocytes in psoriasis.146:50–52.

    Google Scholar 

  19. Fromtling, R. A., andG. K. Abruzzo. 1985. Chemiluminescence as a tool for the evaluation of antimicrobial agents: a review.Meth. Find. Exp. Clin. Pharmacol. 7:493–500.

    Google Scholar 

  20. Bloomfield, F. J., andM. M. C. Young. 1988. Enhanced chemiluminescence production by phagocytosing neutrophils in psoriasis.Inflammation 12:153–159.

    Google Scholar 

  21. Marhoffer, W., M. Stein, E. Keck, andK. Federlin. 1993. Chemilumineszenzinduktion und Funktion neutrophiler Granulozyten bei rheumatoider Arthritis-eine vergleichende Studie.Kassenarzt 52:26–27.

    Google Scholar 

  22. Miesel, R., M. Zuber, D. Sanocka, R. Grätz, andH. Kröger. 1994. The effects of allopurinol in the in vivo suppression of arthritis in mice and the ex vivo modulation of the phagocytic production of oxygen radicals in whole human blood.Inflammation 18:597–611.

    Google Scholar 

  23. Kelley, W. N., E. P. Harris, Jr., S. Ruddy, andC. B. Sledge. 1989.In Textbook of Rheumatology, Saunders, Philadelphia.

    Google Scholar 

  24. Fox, R. J., C. A. Robinson, J. A. Curd, F. Kozin, andF. V. Howell. 1986. Sjoegren's syndrome. Proposed criteria for classification.Arthritis Rheum. 29:577–585.

    Google Scholar 

  25. Tan, E. M., A. S. Cohen, J. F. Fries, A. T. Masi, D. J. McShane, N. F. Rothfield, J. Schaller, N. Talal, andR. J. Winchester. 1982. The 1982 revised criteria for the classification of systemic lupus erythematosus.Arthritis Rheum. 25:1271–1277.

    Google Scholar 

  26. Arnett, F. C., S. M. Edworthy, D. A. Bloch, D. J. McShane, J. E. Fries, N. S. Cooper, L. A. Healey, S. R. Kaplan, M. H. Liang, H. S. Luthra, T. A. Medsger, Jr., D. M. Mitchell, D. H. Neustadt, R. S. Pinals, J. G. Schaller, J. T. Sharp, R. L. Wilder, andG. G. Hunder. 1987. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.Arthritis Rheum. 13:315–324.

    Google Scholar 

  27. Miesel, R., N. Ulbrich, H. Kröger, andA. Mitchison. 1995. Assessment of collagen type II induced arthritis in mice by whole blood chemiluminescence.Autoimmunity 19:153–159.

    Google Scholar 

  28. Duff, G. W. 1994. Cytokines and acute phase proteins in rheumatoid arthritis.Scand. J. Rheumatol. 23:9–19.

    Google Scholar 

  29. van den Hoogen, H. M. M., B. W. Koes, J. T. M. van Eijk, andL. M. Bouter. 1995. On the accuracy of the history, physical examination, and erythrocyte sedimentation rate in diagnosing low back pain in general practice: A criteria-based review of the literature.Spine 20:318–327.

    Google Scholar 

  30. Allen, R. C. 1982. Biochemiexcitation: chemiluminescence and the study of biological oxygenation reactions.In Chemical and Biological Generation of Excited States. W. Adam and P. Cilento, editors. Academic Press, New York, pp. 309–344.

    Google Scholar 

  31. Breedveld, F. 1994. Tenidap: A novel cytokine-modulating antirheumatic drug for the treatment of rheumatoid arthritis.Scand. J. Rheumatol. 23:31–44.

    Google Scholar 

  32. Kushner, I., and A.Mackiewicz. Acute phase proteins as disease markers.Dis. Markers 5:1–21.

  33. Miesel, R., M. Zuber, R. Hartung, R. Haas, andH. Kröger. 1995. Total radical-trapping antioxidative capacity of plasma and whole blood chemiluminescence in patients with inflammatory and autoimmune rheumatic diseases.Redox Report 1:323–330.

    Google Scholar 

  34. Miesel, R., andM. Zuber. 1993. Copper-dependent antioxidase defenses in inflammatory and autoimmune rheumatic diseases.Inflammation 17:283–294.

    Google Scholar 

  35. Miesel, R., M. Kurpisz, andH. Kröger. 1995. Modulation of inflammatory arthritis by inhibition of poly[ADP-ribose]polymerase.Inflammation 19:379–387.

    Google Scholar 

  36. Elliott, M. J., R. M. Maini, M. Feldmann, A. Long-Fox, P. Charles, andF. M. Brenan. 1993. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to TNFα. Safety, clinical efficacy and regulation of the acute phase response.Brit. J. Rheumatol. 32:209–216.

    Google Scholar 

  37. Schreck, R., K. Albermann, andP. A. Baeuerle. 1992. Nuclear factorκB: an oxidative stress-responsive transcription factor of eukaryotic cells [a review].Free Radic. Res. Commun. 17:221–237.

    Google Scholar 

  38. Lenardo, M. J., andD. Baltimore. 1989. NF-κB: a pleiotropic mediator of inducible and tissue-specific gene control.Cell 58:227–229.

    Google Scholar 

  39. Stocker, R., andB. Frei. 1991. Endogenous antioxidant defences in human blood plasma.In Oxidative stress, oxidants and antioxidants. H. Sies, editor. London, Academic Press, 213–243.

    Google Scholar 

  40. Roederer, M., F. J. T. Staal, P. A. Raju, W. Ela, L. A. Herzenberg, andL. A. Herzenberg. 1990. Cytokine-stimulated human immunodeficiency virus replication is inhibited by N-acetyl-L-cysteine.Proc. Natl. Acad. Sci. U.S.A. 87:4884–4888.

    Google Scholar 

  41. Miesel, R., D. Sanocka, M. Kurpisz, andH. Kröger. 1995. Anti-inflammatory effects of NADPH oxidase inhibitors.Inflammation 19:347–362.

    Google Scholar 

  42. Miesel, R., andR. Haas. 1993. Reactivity of an active center analogue of Cu2Zn2 superoxide dismutase in a murine model of acute and chronic inflammation.Inflammation 17:595–611.

    Google Scholar 

  43. Miesel, R., A. Dietrich, B. Brandl, M. Kurpisz, andH. Kröger. 1994. The phagocytic suppression of proinflammatory responses by an active center analogue of Cu2Zn2 superoxide dismutase modulates the onset, progression and remission of arthritis.Rheumatol. Int. 14:119–126.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biochemistry, University of Otago, Dunedin, New Zealand

    Ralf Miesel

  2. Department of Biochemistry, German Rheumatology Research Center, Berlin, Germany

    Ralf Miesel & Hans Kroeger

  3. Charité Hospital, Berlin, Germany

    Robert Hartung

Authors
  1. Ralf Miesel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert Hartung
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hans Kroeger
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Miesel, R., Hartung, R. & Kroeger, H. Priming of NADPH oxidase by tumor necrosis factor alpha in patients with inflammatory and autoimmune rheumatic diseases. Inflammation 20, 427–438 (1996). https://doi.org/10.1007/BF01486744

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01486744

Keywords

Search

Navigation